betaxolol and nitrendipine

betaxolol has been researched along with nitrendipine in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (20.00)	18.2507
2000's	6 (60.00)	29.6817
2010's	2 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Campillo, NE; Guerra, A; Páez, JA	1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A	1
Arakawa, K; Jimi, S; Liu, K; Okamoto, T; Saku, K; Takeda, Y; Zhang, B	1
Melena, J; Osborne, NN; Wood, JP	1
Chao, HM; Chidlow, G; Melena, J; Osborne, NN; Wood, JP	1

Trials

1 trial(s) available for betaxolol and nitrendipine

Article	Year
Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension. Journal of human hypertension, 1996, Volume: 10, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Aged; Apolipoproteins; Betaxolol; Calcium Channel Blockers; Drug Therapy, Combination; Female; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Nitrendipine	1996

Article

Year

Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension.

Journal of human hypertension, 1996, Volume: 10, Issue:4

Topics: Adrenergic beta-Antagonists; Adult; Aged; Apolipoproteins; Betaxolol; Calcium Channel Blockers; Drug Therapy, Combination; Female; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Nitrendipine

1996

Other Studies

9 other study(ies) available for betaxolol and nitrendipine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics	2011
Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels. European journal of pharmacology, 1999, Aug-13, Volume: 378, Issue:3 Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Binding, Competitive; Calcium Channels; Carteolol; Cerebral Cortex; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Membranes; Nitrendipine; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Stereoisomerism; Timolol; Tritium	1999
An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina. Brain research, 2000, Sep-15, Volume: 877, Issue:1 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Batrachotoxins; Betaxolol; Calcium Channel Blockers; Cerebral Cortex; Chick Embryo; Clonidine; Fibroblast Growth Factor 2; Neuroprotective Agents; Neurotoxins; Nitrendipine; Rabbits; Rats; Rats, Wistar; Reactive Oxygen Species; Retina; RNA, Messenger; Saxitoxin; Sodium Channels	2000